533 related articles for article (PubMed ID: 27806179)
1. Evidence-based absorption, distribution, metabolism, excretion (ADME) and its interplay with alternative toxicity methods.
Tsaioun K; Blaauboer BJ; Hartung T
ALTEX; 2016; 33(4):343-358. PubMed ID: 27806179
[TBL] [Abstract][Full Text] [Related]
2. Development and application of physiologically based pharmacokinetic-modeling tools to support drug discovery.
Lüpfert C; Reichel A
Chem Biodivers; 2005 Nov; 2(11):1462-86. PubMed ID: 17191947
[TBL] [Abstract][Full Text] [Related]
3. Physiologically Based Pharmacokinetic (PBPK) Modeling of Pharmaceutical Nanoparticles.
Li M; Zou P; Tyner K; Lee S
AAPS J; 2017 Jan; 19(1):26-42. PubMed ID: 27834047
[TBL] [Abstract][Full Text] [Related]
4. PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: prediction of plasma concentration-time profiles in human by using the physiologically-based pharmacokinetic modeling approach.
Poulin P; Jones RD; Jones HM; Gibson CR; Rowland M; Chien JY; Ring BJ; Adkison KK; Ku MS; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Yates JW
J Pharm Sci; 2011 Oct; 100(10):4127-57. PubMed ID: 21541937
[TBL] [Abstract][Full Text] [Related]
5. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
Singh SS
Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
[TBL] [Abstract][Full Text] [Related]
6. Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: a marriage under the arch of systems pharmacology.
Rostami-Hodjegan A
Clin Pharmacol Ther; 2012 Jul; 92(1):50-61. PubMed ID: 22644330
[TBL] [Abstract][Full Text] [Related]
7. PK/DB: database for pharmacokinetic properties and predictive in silico ADME models.
Moda TL; Torres LG; Carrara AE; Andricopulo AD
Bioinformatics; 2008 Oct; 24(19):2270-1. PubMed ID: 18684738
[TBL] [Abstract][Full Text] [Related]
8. Organs-on-a-chip: Current applications and consideration points for in vitro ADME-Tox studies.
Ishida S
Drug Metab Pharmacokinet; 2018 Feb; 33(1):49-54. PubMed ID: 29398302
[TBL] [Abstract][Full Text] [Related]
9. Physiologically based approaches towards the prediction of pharmacokinetics: in vitro-in vivo extrapolation.
De Buck SS; Mackie CE
Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):865-78. PubMed ID: 18028030
[TBL] [Abstract][Full Text] [Related]
10. A tiered approach to pharmacokinetic studies.
Wilson AG; Frantz SW; Keifer LC
Environ Health Perspect; 1994 Dec; 102 Suppl 11(Suppl 11):5-11. PubMed ID: 7737041
[TBL] [Abstract][Full Text] [Related]
11. The Role of Extracellular Binding Proteins in the Cellular Uptake of Drugs: Impact on Quantitative In Vitro-to-In Vivo Extrapolations of Toxicity and Efficacy in Physiologically Based Pharmacokinetic-Pharmacodynamic Research.
Poulin P; Burczynski FJ; Haddad S
J Pharm Sci; 2016 Feb; 105(2):497-508. PubMed ID: 26173749
[TBL] [Abstract][Full Text] [Related]
12. Systems-ADME/Tox: resources and network approaches.
Ekins S
J Pharmacol Toxicol Methods; 2006; 53(1):38-66. PubMed ID: 16054403
[TBL] [Abstract][Full Text] [Related]
13. The use of pharmacokinetics as an interpretive and predictive tool in chemical toxicology testing and risk assessment: a position paper on the appropriate use of pharmacokinetics in chemical toxicology.
Frantz SW; Beatty PW; English JC; Hundley SG; Wilson AG
Regul Toxicol Pharmacol; 1994 Jun; 19(3):317-37. PubMed ID: 8090955
[TBL] [Abstract][Full Text] [Related]
14. Integration of Engineered Delivery with the Pharmacokinetics of Medical Candidates via Physiology-Based Pharmacokinetics.
Yang Y; Zhang X
Methods Mol Biol; 2022; 2486():57-69. PubMed ID: 35437718
[TBL] [Abstract][Full Text] [Related]
15. The importance of HT-ADME in drug discovery.
Morgan D
Bioanalysis; 2011 Nov; 3(21):2385-7. PubMed ID: 22074279
[TBL] [Abstract][Full Text] [Related]
16. Metabolic stability for drug discovery and development: pharmacokinetic and biochemical challenges.
Masimirembwa CM; Bredberg U; Andersson TB
Clin Pharmacokinet; 2003; 42(6):515-28. PubMed ID: 12793837
[TBL] [Abstract][Full Text] [Related]
17. The role of permeability in drug ADME/PK, interactions and toxicity--presentation of a permeability-based classification system (PCS) for prediction of ADME/PK in humans.
Fagerholm U
Pharm Res; 2008 Mar; 25(3):625-38. PubMed ID: 17710514
[TBL] [Abstract][Full Text] [Related]
18. In silico ADME-Tox modeling: progress and prospects.
Alqahtani S
Expert Opin Drug Metab Toxicol; 2017 Nov; 13(11):1147-1158. PubMed ID: 28988506
[TBL] [Abstract][Full Text] [Related]
19. Toxicology testing in drug discovery and development.
Dorato MA; Buckley LA
Curr Protoc Toxicol; 2007 Feb; Chapter 19():Unit19.1. PubMed ID: 23045141
[TBL] [Abstract][Full Text] [Related]
20. Translational Modeling Strategies for Orally Administered Drug Products: Academic, Industrial and Regulatory Perspectives.
Suarez-Sharp S; Lindahl A; Heimbach T; Rostami-Hodjegan A; Bolger MB; Ray Chaudhuri S; Hens B
Pharm Res; 2020 May; 37(6):95. PubMed ID: 32405699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
